Browse the evidence

Immune system activation (e.g., by microbial challenges) triggers an inflammatory response that increases sleep duration and intensity, serving as a homeostatic regulation of slow-wave sleep.

When you are sick, your body's increased sleep drive is a biological mechanism to help you recover. Listen to this signal and allow yourself to rest, as sleep actively supports your immune defense during infection.

Disease-associated inflammation is a primary etiologic driver of malnutrition, causing anorexia, increased resting energy expenditure, and muscle catabolism, distinct from simple starvation.

In sick patients, malnutrition isn't just about not eating enough; the body's inflammatory response actively breaks down muscle and increases energy needs. Treating the inflammation is as important as providing nutrition.

EPA and DHA stabilize atherosclerotic plaques by reducing macrophage infiltration and matrix metalloproteinase (MMP) expression, thereby lowering the risk of plaque rupture.

For patients with existing atherosclerosis, EPA and DHA supplementation may help stabilize plaques by reducing inflammation within the vessel wall. This is achieved by incorporating into the plaque and reducing macrophage presence, potentially lowering the risk of rupture.

Chronic low-grade inflammation (inflammaging) is a key pathophysiologic association in aging, driven by oxidative stress-induced redox imbalance and the accumulation of senescent cells.

Recognize that chronic, low-grade inflammation is a key driver of aging. Strategies to reduce inflammation, such as managing stress, maintaining a healthy weight, and ensuring adequate sleep, may help mitigate age-related degeneration.

A specific outer membrane protein from Akkermansia muciniphila, Amuc_1100, mediates the metabolic benefits by activating Toll-Like Receptor 2 (TLR2).

The benefits of Akkermansia muciniphila are driven by its outer membrane protein Amuc_1100, which interacts with the immune system (TLR2). This suggests that future therapies might use just this protein rather than the whole bacterium.

Ectopic lipid accumulation in the liver and skeletal muscle is a primary cause of insulin resistance, mediated by lipid metabolites like diacylglycerol (DAG) and ceramides which interfere with insulin signaling pathways.

Focus on reducing fat stored in your liver and muscles, not just overall weight. This can be achieved through modest weight loss, exercise, or specific medical treatments for conditions like NAFLD. Reducing intrahepatic triglycerides dramatically reverses insulin resistance.

Diacylglycerol (DAG) accumulation at the plasma membrane, specifically the sn-1,2 stereoisomer, activates Protein Kinase C (PKC) isoforms (PKCε in liver, PKCθ in muscle), which inhibits insulin signaling.

Not all fat is bad for insulin signaling. It is the specific type and location of fat (DAG at the cell membrane) that blocks insulin. Reducing this specific lipid fraction improves sensitivity.

Obesity-induced chronic low-grade inflammation in adipose tissue acts as a causal mechanism for insulin resistance and type 2 diabetes mellitus.

In obesity, fat tissue doesn't just store energy; it actively releases inflammatory signals that block insulin from working. This inflammation is a key driver of type 2 diabetes risk. While weight loss helps, the inflammatory state itself is a direct cause of metabolic dysfunction, suggesting that managing inflammation is crucial for metabolic health.

Acute or intermittent administration of the flavonoid fisetin acts as a senolytic to clear senescent cells, thereby reducing age-related pathology and extending both healthspan and lifespan in aged mice.

Fisetin is a potent senolytic that extends healthspan and lifespan in mice when administered intermittently at high doses (e.g., 100 mg/kg body weight for 5 days). While human trials are beginning, current evidence supports an intermittent 'hit-and-run' dosing strategy rather than daily supplementation to maximize efficacy and minimize potential side effects. Consult a physician before starting high-dose supplementation.

Obesity promotes aggressive breast cancer behavior (growth, invasion, metastasis) through a mechanism involving hypoxia-induced inflammation, increased aromatase expression, and stimulation of cancer stem cells.

Weight loss interventions aim to break the cycle of obesity-driven inflammation and estrogen production, thereby reducing the fuel for tumor growth and metastasis.

Obesity is associated with an increased risk of triple-negative breast cancer (TNBC) in premenopausal women, whereas this association is null or inverse in postmenopausal women.

For premenopausal women, obesity specifically increases the risk of the more aggressive triple-negative breast cancer subtype. Weight management is particularly crucial in this demographic.

Endogenous oestrogens protect premenopausal women from type 2 diabetes by promoting subcutaneous fat storage, enhancing insulin sensitivity, and preserving beta-cell function, whereas the loss of oestrogen during menopause eliminates this protection and increases diabetes risk.

For women, maintaining metabolic health is heavily influenced by oestrogen levels. Before menopause, your body naturally stores fat in a safer (subcutaneous) way and stays more insulin-sensitive than men. After menopause, this protection fades, increasing diabetes risk. To counter this, focus on preserving muscle mass and managing visceral fat through exercise and diet, as these become more critical once oestrogen levels drop. Discuss hormone therapy options with your doctor if you are at high risk.

Oestrogen receptor alpha (ERα) activation mediates the protective effects of oestrogens on metabolic health by promoting insulin synthesis, beta-cell survival, and energy expenditure through brown adipose tissue beiging.

The protective benefits of oestrogen in women are largely driven by its interaction with specific receptors (ERα) in key metabolic organs. This interaction helps protect the pancreas, improves how muscles use insulin, and boosts energy burning in fat tissue. This highlights why maintaining hormonal balance is crucial for metabolic health.

High BMI acts as a protective factor against breast cancer in females aged 20 to under 50 years, a phenomenon potentially explained by the 'obesity paradox'.

While high BMI is generally harmful, this specific protective effect on breast cancer in younger women is complex and may be due to hormonal factors or methodological issues. It does not justify maintaining a high BMI, as the overall burden of disease from high BMI is substantial.

Pharmacological stimulation of GLP-1 receptors significantly reduces plasma glucose and improves glycaemic control in subjects with type 2 diabetes by preserving insulinotropic and glucagonostatic effects.

For individuals with type 2 diabetes, GLP-1 receptor agonists are a highly effective treatment option. They work by mimicking the natural hormone GLP-1 to lower blood sugar levels. This class of medication is a cornerstone of modern diabetes management due to its ability to improve glycaemic control.

The AGEs/RAGE axis contributes to pancreatic beta cell toxicity and apoptosis via oxidative stress and islet amyloid polypeptide (IAPP) aggregation.

Preserving beta cell function is crucial; strategies that reduce AGEs and oxidative stress may help protect pancreatic beta cells.

Dietary palmitic acid intake does not significantly increase tissue palmitic acid levels because endogenous de novo lipogenesis (DNL) compensates by reducing synthesis, maintaining homeostasis under normal conditions.

If you are metabolically healthy, eating palmitic acid (found in palm oil, meat, dairy) does not automatically raise your body's palmitic acid levels. Your body compensates by making less internally. However, this balance breaks down if you have obesity, insulin resistance, or eat too many sugars, which force your body to overproduce fat.

Consumption of theabrownin, a pigment in Pu-erh tea, lowers serum and hepatic cholesterol and triglycerides by suppressing bile salt hydrolase (BSH) activity in gut microbiota, which increases ileal conjugated bile acids and inhibits the intestinal FXR-FGF15 signaling pathway, thereby stimulating hepatic bile acid synthesis and excretion.

Drinking Pu-erh tea (specifically the fermented variety rich in theabrownin) can help lower cholesterol and triglycerides. This works not by suppressing appetite, but by changing gut bacteria to reduce bile acid breakdown, which signals the liver to burn more cholesterol. A typical effective dose in the study was roughly 300ml of strong Pu-erh tea twice daily for humans, or equivalent purified theabrownin supplementation.

Obesity development is driven by hypothalamic inflammation and insulin/leptin resistance, where peripheral saturated fatty acids cross the blood-brain barrier to trigger microglial activation and ER stress, impairing the ability of hypothalamic neurons to regulate appetite and energy expenditure.

If you are struggling with weight gain despite diet efforts, recognize that high-fat diets can biologically alter brain signaling (insulin/leptin resistance) to promote hunger. This is not a character flaw but a physiological response to specific dietary patterns.

Females in the Asia-Pacific region generally exhibit a higher prevalence of Metabolic Syndrome compared to males, although this varies by specific study and setting.

Women in the Asia-Pacific region face a higher risk of Metabolic Syndrome than men in most studies. This highlights the importance of targeted screening and prevention strategies for women, particularly in urban settings.

Lipopolysaccharide (LPS) translocation from the gut to the blood (metabolic endotoxemia) is a key driver of systemic inflammation, mediated by the TLR4 receptor, and is directly caused by HFD-induced gut barrier dysfunction.

To reduce systemic inflammation, it is not enough to just eat less; you must also protect your gut lining to prevent bacterial toxins (LPS) from entering your bloodstream and triggering an immune response.

Hyperglycemia in Type 2 Diabetes Mellitus causes endothelial dysfunction and platelet hyperactivity through oxidative stress, AGE formation, and PKC activation, leading to accelerated atherosclerosis.

For T2DM patients, controlling blood sugar is not enough to prevent heart disease. You must address the underlying vascular damage caused by high glucose and insulin resistance. This involves managing oxidative stress and inflammation through medication (like SGLT2 inhibitors or GLP-1 agonists mentioned in the text) and lifestyle changes, not just glucose monitoring.

Chronic obesity causes adipose tissue dysfunction through a triad of unresolved inflammation, fibrosis, and impaired angiogenesis, driven by persistent hypoxia and adipocyte death.

Obesity is not just about having too much fat; it is about the fat tissue becoming sick due to lack of oxygen, inflammation, and scarring. Simply losing weight might not fix these underlying tissue issues if the diet and lifestyle don't support healthy tissue remodeling. Focus on strategies that improve metabolic health and reduce inflammation, not just scale weight.

Hypoxia in expanding adipose tissue drives a complex response involving both pro-angiogenic and pro-fibrotic pathways, with HIF-1α playing a dominant pro-fibrotic role in obesity.

Low oxygen levels in fat tissue are a double-edged sword. They try to create new blood vessels, but they also trigger scarring and inflammation. In obesity, the scarring and inflammation often win out, worsening metabolic health.